The development of generic versions of innovator medicines is a global public health need.
Hundreds of global public health experts converged in late May 2023 in Geneva, Switzerland for the 76th meeting of the World Health Assembly (WHA), the decision-making body of the World Health Organization (WHO).
Substandard medicines are a huge public health threat. Proactively evaluating drug products using a relative risk assessment is important to reduce the prevalence of substandard antibiotics.
We have an incredible opportunity to leverage the lessons of the last year to make an even greater impact in 2022. At USP, we are resolving to accelerate our global health efforts in four central areas.
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.
When the UN General Assembly declared March 8 a day to support women's rights and participation in the global arena, it recognized the critical role of women and girls in achieving global development goals.
Show 11 More